Sodium vs Potassium Education to Improve Vascular Health
Improving Vascular Health Using Nutrition Education Aimed At Increasing Potassium Intake Versus Reducing Sodium Intake
2 other identifiers
interventional
32
1 country
1
Brief Summary
The goal of this clinical trial is to determine if a self-selected high potassium diet is easier to achieve and more effective at improving vascular health than a low sodium diet in generally healthy young adults who typically consume more than the recommended amount of sodium. The main questions it aims to answer are:
- 1.Is it easier for young adults to increase their potassium intake, rather than reduce their sodium intake?
- 2.Is a self-selected high potassium diet better at improving vascular health compared to a self-selected low sodium diet?
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable healthy
Started Apr 2026
Typical duration for not_applicable healthy
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 24, 2025
CompletedFirst Posted
Study publicly available on registry
October 28, 2025
CompletedStudy Start
First participant enrolled
April 20, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 30, 2027
April 23, 2026
February 1, 2026
1.4 years
October 24, 2025
April 20, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
Change in dietary sodium intake
Dietary sodium intake will be assessed via participant self-reported 3 day diet record
Baseline; 2 month, 4month, 6month
Change in dietary potassium intake
Dietary potassium intake will be assessed via participant self-reported 3-day diet record
Baseline, 2month, 4month, 6month
Change in 24-hour urinary sodium excretion
Urinary sodium excretion obtained from 24-hour urine sample
Baseline, 2month, 4month, 6month
Change in 24-hour urinary potassium excretion
Urinary potassium excretion measured from 24-hour urine sample
Baseline, 2month, 4month, 6month
Change in Blood pressure
Seated, automated blood pressure mmHg
Baseline; 2 month, 4month, 6month
Change in Endothelial function
brachial artery flow-mediated dilation as measured in % dilation
Baseline; 2 month, 4month, 6month
Secondary Outcomes (2)
Direct measurement of arterial stiffness
Baseline, 2month, 4month, 6month
Indirect measurement of arterial stiffness
Baseline, 2month, 4month, 6month
Other Outcomes (5)
Change in Body weight
Baseline; 2 month, 4month, 6month
Change in total cholesterol
Baseline, 2month, 4month, 6month
Change in LDL cholesterol
Baseline, 2month, 4month, 6month
- +2 more other outcomes
Study Arms (2)
High potassium dietary education
EXPERIMENTALLow sodium dietary education
ACTIVE COMPARATORInterventions
Participants assigned to this intervention arm will receive four weekly individualized education sessions on how to increase their dietary potassium intake.
Participants assigned to this intervention arm will receive four weekly individualized education sessions on how to reduce their dietary sodium intake.
Eligibility Criteria
You may qualify if:
- Willing and able to attend in-person laboratory visits
- Usual sodium intake ≥3,000 mg/d for females and ≥4,000 mg/d for males
- Usual potassium intake ≤2,500 mg/d in females and ≤3,000 mg/d in males
You may not qualify if:
- BMI ≥35 kg/m2
- Seated blood pressure ≥130/80 mmHg
- Current diagnosis or history of diabetes, renal disease, cancer, cardiovascular disease, or major cardiovascular event (e.g. heart attack or stroke)
- Current or recent use of a diuretic (within the past 6 months)
- Elevated blood lipids (LDL cholesterol ≥190 mg/dL)
- Elevated serum potassium level (\>5.1 mmol/L)
- Elevated BUN (\>22 mg/dL)
- Elevated creatinine (\>1.2 mg/dL)
- Low eGFR (\<90 mL/min/1.73 m²)
- Current or recent use of tobacco, nicotine, or illicit drugs
- Radical hysterectomy or oophorectomy (females)\*
- Pregnant or lactating
- Following a weight-loss diet, or intending to gain or lose weight during the study period
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Florida State University
Tallahassee, Florida, 32304, United States
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Andrea Lobene, PhD, RD, LD
Florida State University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
October 24, 2025
First Posted
October 28, 2025
Study Start
April 20, 2026
Primary Completion (Estimated)
September 30, 2027
Study Completion (Estimated)
September 30, 2027
Last Updated
April 23, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share